Stocks and Investing Stocks and Investing
Thu, November 2, 2023

Gil Blum Maintained (SRPT) at Strong Buy with Increased Target to $93 on, Nov 2nd, 2023


Published on 2024-10-28 07:17:42 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $82 to $93 on, Nov 2nd, 2023.

Gil has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Gil's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gil


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $115 on, Tuesday, October 31st, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $148 on, Tuesday, October 31st, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $146 on, Tuesday, October 31st, 2023
  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023

Contributing Sources